Astrazeneca Gets Approval to Sell Lung Cancer Drug in India

Health News
2 min read
Astrazeneca Gets Approval to Sell Lung Cancer Drug in India
Hindi Female

The Quint DAILY

For impactful stories you just can’t miss

By subscribing you agree to our Privacy Policy

Pharmaceutical company AstraZeneca India on 10 March, Wednesday announced that it has received marketing approval for Tagrisso (Osimertinib) for adjuvant treatment after complete tumour resection in patients with non-small cell lung cancer (NSCLC), whose tumours have epidermal growth factor receptor (EGFR) mutations.

Osimertinib, a once daily oral pill, when given to patients of lung cancer whose tumour has a specific mutation called EGFR mutation and who have undergone surgical removal of the lung tumour, has shown to decrease the risk of cancer recurrence by nearly 83 per cent in the ADAURA clinical trial in early stage lung cancer patients, the company said in a statement.

"AstraZeneca has always been and will continue to bring forward world-class treatment solutions for non-communicable diseases," said Gagandeep Singh Bedi, Managing Director, AstraZeneca India.


"The regulatory approval of Tagrisso (Osimertinib) in India will provide better medicine for the management of Non-Small Cell Lung Cancer and help patients attain a better quality of life," Bedi added.

Osimertinib is the first targeted oral treatment option to show such a significant benefit in terms of cancer free survival in early lung cancers with EGFRm positivity.

Cancer spread to the brain and other organs is one of the important cause of recurrence in early stage lung cancer. Osimertinib has shown to decrease the chances of cancer spreading to the brain & other distant organs.

According to the Global Cancer Survey (GLOBOCAN), in 2018, the total number of new lung cancer cases was 67,795 and 63,475 deaths were reported, making lung cancer a very aggressive and devastating cancer.

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT).

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.

Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.

The Quint is available on Telegram & WhatsApp too, click to join.

Read Latest News and Breaking News at The Quint, browse for more from fit and health-news

Topics:  Lung Cancer   Lung Disease   Lung Health 

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More